Therapy Areas: Cardiovascular
Luye Pharma signs contract with AstraZeneca China
18 January 2019 - China-based Luye Pharma has signed a contract with AstraZeneca China, a subsidiary of AstraZeneca, it was reported yesterday.According to the contract, AstraZeneca China has exclusiv...
Amgen & UCB wins the US FDA BRUDAC's recommendation for approval of EVENITY for treating osteoporosis in postmenopausal women
17 January 2019 - Human therapeutics company Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) on Wednesday jointly announced the US Food and Drug Administration (FDA) Bone, Reproductive and Urologi...
Alnylam Pharmaceuticals Prices USD 387.5m Common Stock Offering
15 January 2019 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has priced of an underwritten public offering of 5m shares of its common stock at a public offering ...
Perrigo names new executive vice president and chief scientific officer
15 January 2019 - Ireland-based Perrigo Company plc (NYSE, TASE: PRGO) announced yesterday that it has named James Dillard as its new executive vice president and chief scientific officer.In this new ...
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy
14 January 2019 - - The US Food and Drug Administration accepted for filing the company's New Drug Applications for tafamidis for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). ...
Premier Expands Effort to Supply Shortage Generic Drugs
14 January 2019 - - US-based healthcare improvement company Premier Inc. (NASDAQ: PINC) has established a company to help ensure health systems have continuous and affordable access to shortage medica...
Related Headlines

AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity

Academic Pharmaceuticals receives FDA approval for Bretylium Tosylate Injection

The Medicines Company Completes 5th Review of Un-Dlinded Data and Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase 3 Trials

Amgen & UCB partnership wins marketing authorisation in Japan for EVENITY to treat osteoporosis

RQI Partners LLC partners with careLearning to market, sell and provide customer access to RQI portfolio and vital CPR skills

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases

Ironwood Pharmaceuticals Names Shetzline as Chief Medical Officer

Immunocore Names Jallal as CEO

AstraZeneca makes organisational changes to support growth and focus on main therapy areas

Immunocore names Bahija Jallal new chief executive and director

Biohaven Pharmaceutical Holding Company Ltd submits rimegepant IND application with the NMPA, for the treatment of migraine

Bristol-Myers Squibb's Sprycel Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Dr. Reddy's Laboratories Launches Sevelamer Carbonate for Oral Suspension in the US Market

Lupin and AbbVie Partner to Develop and Commercialise Novel Oncology Drug to Treat Hematological Cancers

Dr. Reddy's Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the US Market